BR0309743A - Processo para a preparação de gama-butirolactamas e gama-aminoácidos altamente funcionalizados - Google Patents

Processo para a preparação de gama-butirolactamas e gama-aminoácidos altamente funcionalizados

Info

Publication number
BR0309743A
BR0309743A BR0309743-9A BR0309743A BR0309743A BR 0309743 A BR0309743 A BR 0309743A BR 0309743 A BR0309743 A BR 0309743A BR 0309743 A BR0309743 A BR 0309743A
Authority
BR
Brazil
Prior art keywords
gamma
butyrolactams
preparation
amino acids
highly functionalized
Prior art date
Application number
BR0309743-9A
Other languages
English (en)
Inventor
Peter Garth Blazecka
James Guy Davidson Iii
Ji Zhang
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BR0309743A publication Critical patent/BR0309743A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/22—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from lactams, cyclic ketones or cyclic oximes, e.g. by reactions involving Beckmann rearrangement
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/18—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/38—2-Pyrrolones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"PROCESSO PARA A PREPARAçãO DE GAMA-BUTIROLACTAMAS E GAMA-AMINOáCIDOS ALTAMENTE FUNCIONALIZADOS". A presente invenção refere-se a um processo para a preparação de <sym>-butirolactamas e <sym>-aminoácidos altamente funcionalizados por aminação redutiva de ácido muco-hálico ou dos seus derivados, e descreve um processo para a preparação de pregabalina ou ácido 3-aminometil-5-metil-octanóico, análogos de GABA com atividade medicinal desejável (Fórmula I).
BR0309743-9A 2002-04-30 2003-04-17 Processo para a preparação de gama-butirolactamas e gama-aminoácidos altamente funcionalizados BR0309743A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37699102P 2002-04-30 2002-04-30
PCT/IB2003/001646 WO2003093220A1 (en) 2002-04-30 2003-04-17 Process for preparing highly functionalized y-butyrolactams and y-amino acids

Publications (1)

Publication Number Publication Date
BR0309743A true BR0309743A (pt) 2005-02-09

Family

ID=29401429

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0309743-9A BR0309743A (pt) 2002-04-30 2003-04-17 Processo para a preparação de gama-butirolactamas e gama-aminoácidos altamente funcionalizados

Country Status (15)

Country Link
US (2) US20030225149A1 (pt)
EP (1) EP1499583A1 (pt)
JP (1) JP2005523932A (pt)
KR (1) KR20040106415A (pt)
CN (1) CN1649827A (pt)
AR (1) AR039467A1 (pt)
AU (1) AU2003219425A1 (pt)
BR (1) BR0309743A (pt)
CA (1) CA2483830A1 (pt)
IL (1) IL164781A0 (pt)
MX (1) MXPA04010771A (pt)
PL (1) PL373296A1 (pt)
RU (1) RU2004131840A (pt)
TW (1) TW200400929A (pt)
WO (1) WO2003093220A1 (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL126999A (en) 1996-07-24 2002-03-10 Warner Lambert Co Pharmaceutical preparations containing isobutylgaba and its history for use in the treatment of pain
MXPA06014228A (es) * 2004-06-21 2007-02-14 Warner Lambert Co Preparacion de pregabalina y compuestos relacionados.
CA2575613C (en) 2004-08-04 2015-05-19 Foam Supplies, Inc. Reactivity drift and catalyst degradation in polyurethane foam
EP1866275A1 (en) * 2005-04-06 2007-12-19 Teva Pharmaceutical Industries Ltd. Crystalline forms of pregabalin
CA2603215A1 (en) * 2005-04-11 2006-10-19 Teva Pharmaceutical Industries Ltd. Process for making (s)-pregabalin
US7488846B2 (en) * 2005-04-11 2009-02-10 Teva Pharmaceuical Industries Ltd. Pregabalin free of lactam and a process for preparation thereof
US7462737B2 (en) 2005-05-10 2008-12-09 Teva Pharmaceutical Industries Ltd. Pregabalin free of isobutylglutaric acid and a process for preparation thereof
US20070043241A1 (en) * 2005-05-10 2007-02-22 Lilach Hedvati Optical resolution of 3-carbamoylmethyl-5-methylhexanoic acid
ATE486841T1 (de) * 2005-05-10 2010-11-15 Teva Pharma Verfahren zur herstellung von pregabalin und salzen daraus
CZ297970B6 (cs) * 2005-08-10 2007-05-09 Zentiva, A. S Zpusob výroby (S)-3-(aminomethyl)-5-methyl-hexanové kyseliny (pregabalinu)
KR20070087596A (ko) * 2005-09-19 2007-08-28 테바 파마슈티컬 인더스트리즈 리미티드 (ｓ)-(+)-3-(아미노메틸)-5-메틸헥산산의 비대칭 합성
BRPI0702865A2 (pt) * 2006-04-24 2012-08-07 Teva Pharma processos para preparaÇço do Ácido 3-isobutilglutÁrico e de (s)- pregabalin, a partir de combinaÇÕes de composiÇÕes com fàrmulas especÍficas para uso na dita preparaÇço
US7462738B2 (en) * 2006-05-24 2008-12-09 Teva Pharmaceutical Industries Ltd. Processes for the preparation of R-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof
EP1912931A2 (en) * 2006-05-31 2008-04-23 Teva Pharmaceutical Industries Ltd. Preparation of (s)-pregabalin-nitrile
KR20080036060A (ko) * 2006-05-31 2008-04-24 테바 파마슈티컬 인더스트리즈 리미티드 프레가발린의 중간체의 제조에 효소 분할을 이용하는 방법
MX2008014759A (es) * 2007-03-22 2009-03-09 Teva Pharma Sintesis del acido (s)-(+)-3-(aminometil)-5-metil hexanoico.
WO2008127646A2 (en) * 2007-04-11 2008-10-23 Dsm Ip Assets B.V. Transaminase-based processes for preparation of pregabalin
KR20100040835A (ko) * 2007-06-05 2010-04-21 아크조 노벨 페인츠 엘엘씨 에폭시화 식물성 오일 유래의 방사선 경화성 코팅 조성물
KR20090101462A (ko) * 2007-10-03 2009-09-28 테바 파마슈티컬 인더스트리즈 리미티드 프레가발린-4-엘리미네이트, 프레가발린 5-엘리미네이트, 기준 마커 및 표준물로서의 이들의 용도, 및 이들을 낮은 수준으로 함유하는 프레가발린의 제조 방법
WO2009081208A1 (en) * 2007-12-26 2009-07-02 Generics [Uk] Limited Processes to pregabalin
JP2010043063A (ja) 2008-05-09 2010-02-25 Agency For Science Technology & Research 川崎病の診断及び治療
US20100087525A1 (en) * 2008-06-23 2010-04-08 Lilach Hedvati Stereoselective enzymatic synthesis of (s) or (r)-iso-butyl-glutaric ester
CN102333801B (zh) 2009-03-05 2015-11-25 阿克佐诺贝尔国际涂料股份有限公司 羟基官能油多元醇丙烯酸类接枝共聚物
WO2011086565A1 (en) * 2010-01-15 2011-07-21 Lupin Limited Method for preparation of enantiomerically enriched and/or racemic gamma-amino acids
WO2012089656A2 (en) 2010-12-28 2012-07-05 Akzo Nobel Coatings International B.V. Radiation curable coating compositions for metal
GB201121317D0 (en) 2011-12-09 2012-01-25 Syngenta Ltd Herbicidal compounds
RU2605418C2 (ru) 2011-12-21 2016-12-20 Акцо Нобель Коатингс Интернэшнл Б.В. Покрывные композиции на основе растворителей
ES2629692T3 (es) 2011-12-21 2017-08-14 Akzo Nobel Coatings International B.V. Composiciones de revestimiento basadas en agua
PL2978748T3 (pl) * 2013-03-27 2017-09-29 Pfizer Ireland Pharmaceuticals Sposób i związki pośrednie do wytwarzania pregabaliny

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3935210A (en) * 1971-07-29 1976-01-27 Sandoz, Inc. Preparation of 1-aryl-4,5-dihalo-pyridazone-6
JP3856816B2 (ja) * 1992-05-20 2006-12-13 ノースウェスターン ユニヴァーシティ 抗発作治療用のｇａｂａ及びｌ−グルタミン酸類縁体
DZ2770A1 (fr) * 1998-04-17 2003-12-01 Lilly Co Eli Procédé de préparation de 1h-indol-3 glyoxamides substituées en position 4.
WO2000002546A2 (en) * 1998-07-09 2000-01-20 Warner-Lambert Company Use of caba-analogues for treating insomnia
ES2317839T3 (es) * 1999-06-10 2009-05-01 Warner-Lambert Company Llc Acidos 3-propil gamma-aminobutiricos monosustituidos.

Also Published As

Publication number Publication date
CA2483830A1 (en) 2003-11-13
US20030225149A1 (en) 2003-12-04
IL164781A0 (en) 2005-12-18
RU2004131840A (ru) 2005-05-27
PL373296A1 (en) 2005-08-22
US6924377B2 (en) 2005-08-02
KR20040106415A (ko) 2004-12-17
WO2003093220A1 (en) 2003-11-13
US20030236415A1 (en) 2003-12-25
AR039467A1 (es) 2005-02-23
MXPA04010771A (es) 2005-03-07
JP2005523932A (ja) 2005-08-11
CN1649827A (zh) 2005-08-03
AU2003219425A1 (en) 2003-11-17
TW200400929A (en) 2004-01-16
EP1499583A1 (en) 2005-01-26

Similar Documents

Publication Publication Date Title
BR0309743A (pt) Processo para a preparação de gama-butirolactamas e gama-aminoácidos altamente funcionalizados
BRPI0016395B8 (pt) derivados de adamantano
BRPI0409109A (pt) novos compostos
BR0314721A (pt) Compostos tricìclicos úteis para tratamento de distúrbios inflamatórios e alérgicos, processo para sua preparação e composições farmacêuticas contendo-os
BR0213380A (pt) Derivados propiÈnicos alfa-oxissubstituìdos por beta-fenila: processo para sua preparação e seu uso na preparação de compostos farmaceuticamente importantes
BR9713465A (pt) Inibidores metalotprotease de amina cìclica sibstituìda
BRPI0409227B8 (pt) &#34;composto, composição farmacêutica, uso de um composto e processo para a preparação de um composto de fórmula (i)&#34;
BR0214243A (pt) Derivado de sulfonamida processo para a preparação de um derivado de sulfonamida e seus sais fisiologicamente aceitáveis, composição farmacêutica e uso de um derivado de sulfonamida
NO20083956L (no) Prodrugs av GABA-analoger, sammensetninger og anvendelse derav
BR0314314A (pt) Derivados do éter 4-pirrolidina-fenil-benzìlico
BR0310077A (pt) Novos compostos e sua utilização
BRPI0008753B8 (pt) composto de amida, processo para preparar um composto de amida, composição farmacêutica e uso de um composto de amida
BR0311984A (pt) Difenilazetidinonas substituìdas cationicamente, processo para a sua preparação, medicamentos contendo estes compostos e sua aplicação
BR0206935A (pt) Composto, formulação farmacêutica, uso de um composto, método de tratamento e/ou profilaxia de condições associadas com a inibição da glicogênio sintase quinase-3, e, processo para a preparação de um composto
BR0212069A (pt) Agentes antidiabéticos orais
BRPI0208468B8 (pt) camsilato de amlodipina e processo para sua preparação
WO2006047575A3 (en) Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
BR0301667A (pt) Processo para a preparação de polìmeros em emulsão com pureza elevada
BR0012631A (pt) Processo para a preparação de compostos de amina
BRPI0409038A (pt) processos para preparação de um produto de reação, de uma composição farmacêutica, de uma composição agroquìmica, de uma composição de limpeza, de uma composição de tinta e de um refrigerante ou lubrificante
BR0206730A (pt) Processo para preparar uma composição de valproato de sódio não-higroscópica, composição farmacêutica não-higroscópia e seu uso
BR0010225A (pt) Composto de amida, processo para prepará-lo, composição farmacêutica compreendendo dito composto, método de tratamento e uso
NO20081675L (no) Cykliske N-[1,3,4]-tiadiazol-2-yl-benzensulfonamlder, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika
BRPI0408270A (pt) composição farmacêutica compreendendo ácido 5-metil-2-(2&#39;cloro-6&#39;-fluoroanilino)fenilacético
BR0307009A (pt) Sais estáveis de ácido o-acetilsalicìlico com aminoácidos básicos ii

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2051 DE 27/04/2010.

B08J Incorrect entry in the gazette republished [chapter 8.10 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2105 DE 10/05/2011. TEXTO CORRETO: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2055 DE 25/05/2010.